Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: What are the direct costs of assisted reproductive technology (ART), and how affordable is it for patients in low- and middle-income countries (LMICS)? SUMMARY ANSWER: Direct medical costs paid by patients for infertility treatment are significantly higher than annual average income and GDP per capita, pointing to unaffordability and the risk of catastrophic expenditure for those in need. WHAT IS KNOWN ALREADY: Infertility treatment is largely inaccessible to many people in LMICs. Our analysis shows that no study in LMICs has previously compared ART medical costs across countries in international dollar terms (US$PPP) or correlated the medical costs with economic indicators, financing mechanisms, and policy regulations. Previous systematic reviews on costs have been limited to high-income countries while those in LMICs have only focussed on descriptive analyses of these costs. STUDY DESIGN, SIZE, DURATION: Guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA), we searched PubMed, Web of Science, Cumulative Index of Nursing and Allied Health Literature, EconLit, PsycINFO, Latin American & Caribbean Health Sciences Literature, and grey literature for studies published in all languages from LMICs between 2001 and 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: The primary outcome of interest was direct medical costs paid by patients for one ART cycle. To gauge ART affordability, direct medical costs were correlated with the GDP per capita or average income of respective countries. ART regulations and public financing mechanisms were analyzed to provide information on the healthcare contexts in the countries. The quality of included studies was assessed using the Integrated Quality Criteria for Review of Multiple Study designs. MAIN RESULTS AND THE ROLE OF CHANCE: Of the 4062 studies identified, 26 studies from 17 countries met the inclusion criteria. There were wide disparities across countries in the direct medical costs paid by patients for ART ranging from USD2109 to USD18 592. Relative ART costs and GDP per capita showed a negative correlation, with the costs in Africa and South-East Asia being on average up to 200% of the GDP per capita. Lower relative costs in the Americas and the Eastern Mediterranean regions were associated with the presence of ART regulations and government financing mechanisms. LIMITATIONS, REASONS FOR CAUTION: Several included studies were not primarily designed to examine the cost of ART and thus lacked comprehensive details of the costs. However, a sensitivity analysis showed that exclusion of studies with below the minimum quality score did not change the conclusions on the outcome of interest. WIDER IMPLICATIONS OF THE FINDINGS: Governments in LMICs should devise appropriate ART regulatory policies and implement effective mechanisms for public financing of fertility care to improve equity in access. The findings of this review should inform advocacy for ART regulatory frameworks in LMICs and the integration of infertility treatment as an essential service under universal health coverage. STUDY FUNDING/COMPETING INTEREST(S): This work received funding from the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (WHO). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: This review is registered with PROSPERO, CRD42020199312.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due to high cost and/or unaffordability, ART remains out of reach for many, even in resource-rich countries (Dyer et al., 2020; ASRM The Ethics Committee, 2021; Njagi et al., 2023).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Njagi et al., 2023
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Systematic reviews have shown that individuals with infertility problems in LMICs are less likely to have access to any form of ART [31,34], even routine medical care, including psychosocial interventions [35].”
The cited source says what the claim attributes to it.
In the citing paper
“Infertility treatment is disproportionately underutilized in LMICs [30,31] due to the high cost of treatment and the limited financial resources of those affected.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While psychosocial interventions are conceptualized in high-income countries and incorporated in the health systems, LMICs are yet to incorporate them in the management of infertility [31].”
From Psychosocial interventions for improving marital intimacy, sexual satisfaction, and quality of life of women and couples with infertility problems in low and middle-income countries: Systematic review protocol (2025) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“In keeping with the study protocol published in the PROSPERO database (CRD42020199312) and elsewhere (Njagi et al., 2020), this study was conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement (Moher et al., 2009).”
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Boivin, J., Bunting, L., Collins, J. A., & Nygren, K. G. (2007) · Human Reproduction · doi:10.1093/humrep/dem046 · Cited by 2,437 · cited 2×
“While reported prevalence estimates vary widely due to different methodologies, global estimates show that between 48.5 and 72.4 million couples have infertility (Boivin et al., 2007; Mascarenhas et al., 2012).”
InfluentialDevelopment of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)
Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011458 · Cited by 2,376 · cited 1×
“For cross-sectional studies, we applied the criteria for non-controlled studies complemented by the quality assessment tool for observational and cross-sectional studies provided by the National Institutes of Health (Downes et al., 2016; Ma et al., 2020).”
MethodMascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S., & Stevens, G. A. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001356 · Cited by 2,312 · cited 4×
“However, infertility is itself a widely prevalent cause of significant health burden for millions of people (Makuch et al., 2010; Mascarenhas et al., 2012; Cox et al., 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al.”
BackgroundInfluentialInternational Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · A Companion to the Classification of Mental Disorders · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,059
Inhorn, M. C., & Patrizio, P. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv016 · Cited by 1,926 · cited 2×
“intervention throughout the world (Bitler and Schmidt, 2012; Inhorn and Patrizio, 2015; Sharma et al., 2018).”
BackgroundMa, L.-L., Wang, Y.-Y., Yang, Z.-H., Huang, D., Weng, H., & Zeng, X.-T. (2020) · Military Medical Research · doi:10.1186/s40779-020-00238-8 · Cited by 1,648
Starrs, A. M., Ezeh, A. C., Barker, G., Basu, A., Bertrand, J. T., Blum, R., Coll-Seck, A. M., Grover, A., Laski, L., Roa, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30293-9 · Cited by 1,598 · cited 2×
“, 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al., 2018).”
Background
Research works printed but not linked: 9
- International Federation of Fertility Societies’ Surveillance (IFFS), 2019, Global trends in reproductive policy and practice, Glob Reprod Health, 4, e29
- Inhorn, 2012, Infertility and assisted reproduction in the muslim middle east: social, religious, and resource considerations, Facts Views Vis ObGyn, 6, 24
- Khalifa, 2012, Reviewing infertility care in Sudan; socio-cultural, policy and ethical barriers, Facts Views Vis ObGyn, 53
- Sangamithra, 2015, An economic analysis of socio-economic variables and treatment cost of infertility, Shanlax Int J Econ, 3, 5
- Tangwa, 2002, ART and African sociocultural practices: worldview, belief and value systems with particular reference to francophone Africa, Vayena E Curr Pract Controv Assist Reprod, 5, 55
- WHO, 2020, Infertility Fact Sheet
- World Bank, 2021, Low and Middle Income Countries: World Bank Open Data
- World Bank, 2021, PovcalNet
- World Bank, 2021, GDP per capita, PPP (Current International $) International Comparison Program, World Development Indicators Database
Cited by
Fauser, B. C. J. M., Adamson, G. D., Boivin, J., Chambers, G. M., de Geyter, C., Dyer, S., Inhorn, M. C., Schmidt, L., Serour, G. I., Tarlatzis, B., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmad028 · Cited by 224
“Due to high cost and/or unaffordability, ART remains out of reach for many, even in resource-rich countries (Dyer et al. , 2020; ASRM The Ethics Committee, 2021; Njagi et al. , 2023).”
BackgroundSelf-citationEmbryo selection through artificial intelligence versus embryologists: a systematic review
Salih, M., Austin, C., Warty, R. R., Tiktin, C., Rolnik, D. L., Momeni, M., Rezatofighi, H., Reddy, S., Smith, V., Vollenhoven, B. J., et al. (2023) · Human Reproduction Open · doi:10.1093/hropen/hoad031 · Cited by 191
“Annually, the estimated number of couples experiencing infertility worldwide is around 17.5% of the adult population (one in six) (Njagi et al. , 2023).”
InfluentialGaillard, L., Barouki, R., Blanc, É., Coumoul, X., & Andréau, K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.021 · Cited by 143
Feng, J., Wu, Q., Liang, Y., Liang, Y., & Bin, Q. (2025) · Reproductive Health · doi:10.1186/s12978-025-01966-7 · Cited by 115
“In low-and middle-income countries, the lack of gov-ernment-funded infertility treatments and insurance coverage further limits access, leaving many couples to pay out of pocket, which can lead to significant financial hardship [13].”
Wang, Y., Li, R., Yang, R. J., Zheng, D., Zeng, L., Lian, Y., Zhu, Y., Zhao, J., Liang, X., Li, W., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02416-9 · Cited by 87
Aitken, R. J. (2024) · Frontiers in Reproductive Health · doi:10.3389/frph.2024.1364352 · Cited by 83
Baker, V. L., Dyer, S., Chambers, G. M., Keller, E., Banker, M., de Mouzon, J., Elgindy, E. A., Bai, F., Ishihara, O., Jwa, S. C., et al. (2025) · Human Reproduction · doi:10.1093/humrep/deaf049 · Cited by 42
Self-citationSfakianoudis, K., Zikopoulos, A., Grigoriadis, S., Seretis, N., Maziotis, E., Anifandis, G., Xystra, P., Kostoulas, C., Giougli, U., Pantos, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094977 · Cited by 33
“The increasing prevalence of infertility highlights the urgent need to improve our understanding of the pathophysiological mechanisms through which the reproductive dynamic is compromised, with a view to improving reproductive health care in an era of precision and personalized medicine [108].”
BackgroundAntioxidants in mitigating phthalate-induced male reproductive toxicity: A comprehensive review
Mondal, S., & Bandyopadhyay, A. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143297 · Cited by 33
Li, S., Kumar, S., Gu, X., & DeFalco, T. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101323 · Cited by 36
Access to assisted reproductive technologies in sub-Saharan Africa: fertility professionals’ views
Whittaker, A. M., Gerrits, T., Hammarberg, K., & Manderson, L. H. (2024) · Sexual and Reproductive Health Matters · doi:10.1080/26410397.2024.2355790 · Cited by 44
“Njagi et al 14 list the major drivers of costs in assisted reproduction as: direct medical costs (payments for diagnosis, procedural costs, laboratory tests, and drugs/medications) and indirect costs (food, accommodation, and travel for patients living remotely from the treatment institutions).”
BackgroundFulfilment of fertility desires for the attainment of global sustainable development goals
Mburu, G., Kamuyango, A., Kidula, N., Kabra, R., Thatte, N., Kiarie, J., & Allotey, P. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012322 · Cited by 21
Self-citationLiu, X., Zeng, T., Zhang, E., Bin, C., Liu, Q., Wu, K., Luo, Y., & Wei, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1650347 · Cited by 40
Achieving more equitable access to assisted reproduction
Dyer, S., Adamson, G. D., Inhorn, M. C., & Zegers-Hochschild, F. (2024) · BMJ · doi:10.1136/bmj-2023-077111 · Cited by 19
Self-citationSalih, M., Austin, C., Mantravadi, K., Seow, E., Jitanantawittaya, S., Reddy, S., Vollenhoven, B. J., Rezatofighi, H., & Horta, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-02076-x · Cited by 25
Grulich, A. E., Mercer, C. H., Sturrock, B. R., Baral, S., Turpin, N., Phanuphak, N., Rowley, J. T., Wi, T., Gemzell‐Danielsson, K., Garcia‐Moreno, C., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01188-2 · Cited by 29
Self-citationRisk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss
Borsi, E., Potre, O., Ioniță, I., Samfireag, M., Secoşan, C. A., & Potre, C. (2024) · Medicina · doi:10.3390/medicina60040521 · Cited by 22
“Furthermore, understanding the cost effectiveness and the psychological impact of thrombophilia screening and the associated assisted reproductive techniques is crucial for developing guidelines and recommendations for its use in clinical practice [26,27].”
BackgroundLi, B., Chen, H., Lin, X., & Duan, H. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001241 · Cited by 17
“For individuals encountering challenges in nat-ural conception, the implementation of appropriate assisted reproductive criteria has emerged as the optimal strategy for enhancing IUAs pregnancy rates while simultaneously optimizing treatment ef fi ciency and resource allocation [8,9] .”
BackgroundMethodSexual Health in Low- and Middle-Income Countries (LMICs)
Morgan, S., Kelland, S., & Cassie, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-66563-9_8 · Cited by 16
Applications of single-cell RNA sequencing in spermatogenesis and molecular evolution
Chen, W., 西北农林科技大学动物医学院陕西省干细胞工程技术研究中心, 陕. 杨. 7., Zhang, M., Yang, F., Hua, J.-L., & 西北农林科技大学家畜生物学重点实验室, 陕. 杨. 7. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2024.010 · Cited by 15
Xi, H., Huang, L., Qiu, L., Li, S., Yan, Y., Ding, Y., Zhu, Y., Wu, F., Shi, X., Zhao, J., et al. (2024) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2024.100268 · Cited by 14
“Hence, novel methodologies are imperative to enhance the quality of IVM oocytes, thereby refining the effectiveness of IVF and ICSI techniques.”
InfluentialTrends and Distribution of Infertility — Asia Pacific Region, 1990–2021
Luo, Y., Hong, C., Fan, H., Huang, Y., Zhong, P., Zhao, Y., & Zheng, X. (2024) · China CDC Weekly · doi:10.46234/ccdcw2024.155 · Cited by 20
The role of p53 in male infertility
Li, J., Huang, X., Lei, L., Sun, J., Guo, Q., Yang, X., Zhang, C., & Ni, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1457985 · Cited by 19
“Although the use of assisted reproductive technology (ART) can bring dawn to infertile men, it is not always a panacea, and its safety has been questioned because of comorbidities in the offspring (12).”
BackgroundFactors associated with discontinuation in fertility treatment: a systematic scoping review
Shen, Q., Wang, B., He, T., Li, S., Peng, E., & Lei, J. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02982-x · Cited by 17
“Moreover, patients who discontinued treatment may lead to economic losses since the direct cost of ART treatment is ranged from $2109 to $18,592 per one fresh cycle in different countries [7].”
Bueno-Sánchez, L., Alhambra‐Borrás, T., Gallego‐Valadés, A., & Ferrer, J. G. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21020158 · Cited by 20
“In addition, it often entails a large financial cost for couples [4].”
BackgroundOmbelet, W., Blerkom, J. V., Boshoff, G., Huyser, C., Lopes, F., Nargund, G., Sallam, H. N., Vanmechelen, K., & Campo, R. (2025) · Human Reproduction Open · doi:10.1093/hropen/hoaf001 · Cited by 19
Tian, X., Qin, B., Li, Y., Li, H., & Zhou, W. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118825 · Cited by 19
Tholeti, P., Uppangala, S., Kalthur, G., & Adiga, S. K. (2024) · Reproduction and Fertility · doi:10.1530/raf-24-0079 · Cited by 14
Global burden of cardiovascular disease due to low physical activity, 1990–2021
Wu, N., Wang, J., Hu, Y., Du, T., Shu, P., Shen, C., & Chen, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-11329-8 · Cited by 14
“A recent meta-analysis showed that 49.2% of adults and 74.4% of adolescents in the region were not sufficiently physically active 30 .”
InfluentialAdhikary, P., Mburu, G., Kabra, R., Habib, N. A., Kiarie, J., Dhabhai, N., Chowdhury, R., & Mazumder, S. (2024) · PLOS ONE · doi:10.1371/journal.pone.0304029 · Cited by 11
Self-citationTian, Y., Wang, H., Pan, T., Hu, X.-N., Ding, J., Chen, Y., Li, J. X., Chen, H., & Luo, T. (2024) · Journal of Proteomics · doi:10.1016/j.jprot.2024.105213 · Cited by 10
Xie, Y., Peng, C., He, J., 向极仲, & Wang, Z. (2025) · Veterinary Sciences · doi:10.3390/vetsci12060585 · Cited by 14
Appiah, D., & Ganle, J. K. (2024) · BMC Medical Ethics · doi:10.1186/s12910-024-01113-0 · Cited by 10
“For instance, those who opt to treat infertility spend considerable time and money, and these expenses are often paid out of pocket, unleashing financial strain and potentially bankruptcy [6, 7].”
BackgroundLi, X., Wu, X., Zhang, H., Liu, P., Xia, L., Zhang, N., Tian, L., Li, Z., Lu, J., Zhao, Y., et al. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01321-8 · Cited by 9
“The worldwide prevalence of infertility among reproductive-aged couples ranges between 12.6% and 17.5% [1].”
InfluentialHe, O., Chen, D., & Li, Y. (2025) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1640612 · Cited by 10
Afferri, A., Dierickx, S., Allen, H., Bittaye, M., Marena, M., Pacey, A. A., & Balen, J. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10701-0 · Cited by 12
“The high cost of assisted reproductive technologies (ARTs) makes it pro-hibitive in the context of many national health budgets, although other components of fertility care are less costly [14].”
Makieva, S., Saenz-de-Juano, M. D., Almiñana, C., Bauersachs, S., Bernal-Ulloa, S. M., Xie, M., Gil, A. V., Cervantes, N., Sachs, M., Ulbrich, S. E., et al. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag021 · Cited by 8
“Even milder stimulation approaches pro-foundly influence a couple’s experience undergoing infertility treatment (Njagi et al. , 2023).”
Fu, Y., Sun, X., Kayimu, K., Chen, G., Wang, Y., & Yang, F. (2024) · Reproductive Health · doi:10.1186/s12978-024-01906-x · Cited by 7
“To mitigate this risk factor, inclusion of ART treatments in medical insurance reimbursement may ease this tension and facilitate more equitable access to reproductive health services [41].”
Experiences of infertility among couples in Morocco
Benbella, A., Mburu, G., Zaidouni, A., Elomrani, S., Yahyane, A., Gholbzouri, K., Kiarie, J. N., & Bezad, R. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2024.1513243 · Cited by 8
Self-citationLIFR-Mediated ERBB2 Signaling Is Essential for Successful Embryo Implantation in Mice
Terakawa, J., Nakamura, S., Ohtomo, M., Uehara, S., Kawata, Y., Takarabe, S., Sugita, H., Namiki, T., Kageyama, A., Noguchi, M., et al. (2025) · Biomolecules · doi:10.3390/biom15050698 · Cited by 9
“Infertility, defined as the inability to conceive after 12 months or more of regular unprotected sexual intercourse, affects millions of individuals worldwide [1].”
Guo, Y., Xia, P., Tian, Y., Fu, D., Hu, X., Xie, K., Dong, W., Zhang, W., Liu, D., Shen, R., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02641-3 · Cited by 8
“According to the WHO report, about 17.5% of adults (about one-sixth of the global population) are suffering from infertility [1].”
InfluentialHu, L., Yuan, Y., Li, Y., Cai, M., Yin, J., & Zhu, L. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1701381 · Cited by 7
“…such as Africa and Southeast Asia, despite the fact that assisted reproductive technology (ART) is a successful treatment for infertility (89, 101) Furthermore, several cycles are frequently needed to produce a successful pregnancy because the clinical pregnancy rate for assisted…”
Mabweazara, G. M., Hammarberg, K., & Mhazo, P. (2024) · Culture Health & Sexuality · doi:10.1080/13691058.2024.2403104 · Cited by 7
“Most ART centres in Africa are operated for profit, with <10% being university-based and only 10.9% being non-academic public ART clinics (Karaga et al. 2023; Njagi et al. 2023).”
InfluentialXiao, X., Han, Y., Li, Q., Zheng, D., Cheng, C. Y., & Ni, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1281812 · Cited by 6
Dwojak, E., Mroczek, M., Dworacki, G., Dobosz, P., Ślubowska, A., Stępień, M., Borowczyk, M., Filipczyńska, I., Tomaszewska, A., Ałtyn, R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313083 · Cited by 6
Integration of Bioengineered Tools in Assisted Reproductive Technologies
Ak, A., Coonen, E., van Golde, R. J. T., & Vrij, E. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500918 · Cited by 7
Glycerol Kinase 2 as a Metabolic Sentinel for Human Sperm Motility and Male Fertility
Oliveira, J. P., Moreira, R., Martins, A. D., Alves, M. G., & Oliveira, P. F. (2025) · Biomolecules · doi:10.3390/biom15091249 · Cited by 6
“Additionally, building ART centers and the treatment itself are costly and not equally accessible in all countries, as the financial burden of an ART treatment differs in different countries, as a result of the absence of financing from the government or the yearly income of the patients [20].”
Alesi, S., Grieger, J. A., Teede, H. J., Hébert, J. R., Moss, R. K., Price, S., Hodge, A. M., Moran, L., & Mousa, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1682549 · Cited by 9
“Individuals with infertility often endure substantial emotional distress and a diminished quality of life, which adversely impact mental health and interpersonal relationships (3, 4).”
WHO guideline on infertility: an opportunity to reduce global health inequalities
Mburu, G., Kiarie, J. N., & Allotey, P. A. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00227-x · Cited by 11
Self-citationPrevalence and help-seeking for infertility in a population with a low fertility rate
Lee, M.-C., Chien, P.-S., Zhou, Y., & Yu, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306572 · Cited by 8
Yue, X., Li, Q., Tao, J., Zhang, H., Peng, J., Zhang, D., Yang, J., Ji, D., Tao, F., Cao, Y., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117144 · Cited by 10
Wang, J. H., Liu, Z., Zhang, C., Cao, Y., Liu, B., Shu, Y., Thum, Y., & Zhang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-92186-3 · Cited by 6
Women’s health in 2024: change now for tomorrow will be too late
Carneiro, M. M. (2023) · Women & Health · doi:10.1080/03630242.2024.2292320 · Cited by 6
“Financial and geographical barriers limit access to advanced treatments such as in vitro fertilization (IVF) and may further increase the gender gap as women tend to carry the infertility burden on their own (Njagi et al. 2023).”
BackgroundMabweazara, G. M. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.25804576 · Cited by 8
Jackuliak, P., Jankovský, M., Kovářová, M., Voller, J., Feitscherova, C., & Varga, I. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1582039 · Cited by 6
Xie, G., Zhou, Y., Zheng, Q., Wang, L., Wang, Y., Zeng, H., Wang, J., & Li, X. (2025) · Reproductive Toxicology · doi:10.1016/j.reprotox.2025.108948 · Cited by 7
Lutkiewicz, K., Bieleninik, Ł., Jurek, P., & Bidzan, M. (2025) · Journal of Reproductive and Infant Psychology · doi:10.1080/02646838.2025.2513662 · Cited by 5
Zhang, H., Li, Y., Zhu, N., Liu, Q., Cai, J., Wen, Y., Liu, T., & Han, F. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115703 · Cited by 7
Paracetamol (N-acetyl-para-aminophenol) disrupts early embryogenesis by cell cycle inhibition
Nielsen, B. S., Petersen, M. R., Gonzalez, J. M., Holmberg, C., Mjoseng, H. K., Frederiksen, H. W., Rosenthal, C., Jørgensen, E., Serup, P., Christensen, S. L., et al. (2025) · Human Reproduction · doi:10.1093/humrep/deaf116 · Cited by 7
Mesfin, M. D., Galgalo, D. A., Atmaca, L., Kovács, K. A., Várnagy, Á., & Prémusz, V. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1678033 · Cited by 5
Ombelet, W., Goemaes, R., Fomenko, E., & Campo, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113683 · Cited by 5
“Direct medical costs paid by patients are significantly higher than the annual average income and GDP per capita, pointing to unaffordability and lack of access [26].”
BackgroundWang, J., Jiang, S., Shi, J., Wang, J., Du, S., & Huang, Z. (2024) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545825500038 · Cited by 6
Women’s expectations of infertility care in Ghana: A qualitative study
Armah, D., van der Wath, A., Yazbek, M., & Naab, F. (2024) · International Journal of Africa Nursing Sciences · doi:10.1016/j.ijans.2024.100802 · Cited by 5
Njagi, P., Groot, W. N. J., Arsenijevic, J., Mburu, G., Chambers, G. M., Calhaz–Jorge, C., & Kiarie, J. N. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318780 · Cited by 11
Self-citationSchreck, L. D., Meyer, S., Pedersen, E. S. L., Lam, Y. T., Silberschmidt, H., Bellu, S., Living with PCD patient advisory group, Zambrano, S. C., Kuehni, C. E., & Goutaki, M. (2025) · Health Expectations · doi:10.1111/hex.70316 · Cited by 6
“Additionally, for many individuals, advanced fertility treatments like IVF are not affordable because of their healthcare system [26].”
Boshoff, G., Ombelet, W., & Huyser, C. (2025) · Reproduction and Fertility · doi:10.1530/raf-24-0072 · Cited by 8
Barraza, J., Cleofas, P., Villamil, S., García, M., López, A., Casas, E., Salazar, Z., Pichardo, F., Barajas‐Salinas, A., Núñez‐Macías, E., et al. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4650 · Cited by 6
“In low-and middle-income countries, which constitute approximately 80% of the world's population, access to these treatments is limited due to their high costs (Njagi et al., 2023).”
Pathak, B. G., Mburu, G., Habib, N., Kabra, R., Kiarie, J. N., Chowdhury, R., Dhabhai, N., & Mazumder, S. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-001740 · Cited by 5
Self-citationAhmadi, P., Bayat, N., & Abbasi, B. (2024) · Journal of Nutritional Science · doi:10.1017/jns.2024.81 · Cited by 4
CHIR99021 Enhances the Proliferation of Mouse Female Germline Stem Cells Via Modulating ERCC2
Jia, Q., Tian, G. G., Li, X., & Wu, J. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01877-9 · Cited by 4
“Infertility affects approximately 15% of reproductive-aged couples worldwide, and about half of these cases are solely attributed to female factors [1].”
Li, B., Chen, H., & Duan, H. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.02.014 · Cited by 4
“While assisted reproductive technologies (ART) can improve pregnancy rates for postoperative patients, they come with higher costs [ 5 , 6 ].”
The Intersection of Technology and Health Economics: Innovations and Challenges
Shah, S. S. (2024) · Premier journal of public health. · doi:10.70389/pjph.100004 · Cited by 5
Araya, B. M., Vélez, M. P., Gelaye, K. A., Dyer, S., Andualem, H. T., & Aldersey, H. M. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70001 · Cited by 10
“50 The strong religious beliefs of the women—Orthodox Christianity and Islam—prominently shaped the women's infertility journeys, serving as both a spiritual need and a coping strategy.”
Self-citationRecent advances in the management of male infertility
Rowaiee, R. K., Almidani, O., & Raheem, O. A. (2025) · Asian Journal of Andrology · doi:10.4103/aja20257 · Cited by 4
Cummings, J., & Beynon‐Jones, S. M. (2025) · Sex & Sexualities · doi:10.1177/3033371251330247 · Cited by 4
Kisspeptins Regulating Fertility: Potential Future Therapeutic Approach in Infertility Treatment
Kotanidou, S., Nikolettos, N., Kritsotaki, N., Tsikouras, P. N., Tiptiri-Kourpeti, A., & Nikolettos, K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103284 · Cited by 7
“Worldwide, it presents in 8–12% of reproductive-age couples and can result from factors related to either the female and/or male partner [2].”
Endocrine Disruption as a Mediator of Declining Semen Quality in Smokers
Choudhury, B. P., Das, S., Kar, K. K., Sláma, P., Kolesárová, A., Rosas, I. M., & Roychoudhury, S. (2025) · Cells · doi:10.3390/cells14171345 · Cited by 6
“Infertility is one of the primary health concerns around the world, with prevalence ranging between 12.6% and 17.5% among couples of reproductive age [1].”
InfluentialOptoelectronic Tweezers Platform for Label‐Free and Automated Multidimensional Sperm Manipulation
Huang, S., Zhao, J., Gan, C., Zeng, Z., Xiong, H., Ye, J., Sun, H., Niu, W., Wang, A., Li, C., et al. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202501167 · Cited by 3
Health-seeking behavior for infertility: A systematic review and meta–analysis
Elumalai, R., Jaisankar, S., Bagepally, B. S., Vembu, R., & Bhatnagar, T. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.114777 · Cited by 7
Boshoff, G., Huyser, C., & Ombelet, W. U. A. M. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.105411 · Cited by 3
Chu, M., Ma, D., Song, Z., Liang, L., Xing, F., & Bao, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1671848 · Cited by 3
“…(10), affects approximately 30% of women in unexplained infertility, particularly those with recurrent implantation failure, recurrent spontaneous abortion, and recurrent pregnancy loss (11 – 13), yet current empiric antibiotic regimens fail in > 40% of cases due to non-microbial drivers (14, 15).”
Dabiri, M., Goss, D. M., Vasilescu, S., & Warkiani, M. E. (2026) · Andrology · doi:10.1111/andr.70198 · Cited by 6
Wang, Y., Wang, R., Lian, Y., Yang, R., Gao, J., Liu, J., Tang, L., Liang, X., Cao, Y., Li, W., et al. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag011 · Cited by 4
Fertility by Design: Integrating IVF, Biopsychosocial Tenets, and Counseling
Bjornsen, A. L., Schneider, K. M., Blount, A. J., & Hellman, S. (2024) · The Family Journal · doi:10.1177/10664807241231256 · Cited by 3
“In fact, one in six adults struggle with fertility (Njagi et al., 2023; WHO, 2023).”
BackgroundInfluentialSperm Manipulation and Selection Platform Using Optoelectronic Tweezers*
Huang, S., Zhac, J., Gan, C., Xiong, H., Ye, J., Sun, H., Niu, W., Wang, A., Chen, B., Zeng, Z., et al. (2024) · IEEE International Conference on Robotics and Biomimetics (ROBIO) · doi:10.1109/robio64047.2024.10907732 · Cited by 3
“According to the latest statistics from the World Health Organization, approximately 17.5% of adults worldwide suffer from infertility, with male factors accounting for half of these cases[1].”
InfluentialChaudhary, A., More, A., Choudhary, N., Barai, J., & Wadhe, T. (2025) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_166_25 · Cited by 3
von Wiegen, N., Behl, C., & Körschgen, H. (2025) · iScience · doi:10.1016/j.isci.2025.112976 · Cited by 3
“This offers considerable potential not only to reduce the constantly rising financial costs of assisted reproductive technologies (ART) 3,4 but also equally to reduce potentially harmful side effects for treated individuals.”
Hojeij, B., Schoenmakers, S., van Rossem, L., Willemsen, S. P., Baart, E. B., Rousian, M., & Steegers‐Theunissen, R. P. M. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03688-y · Cited by 2
Medicine and the Cybernetic Revolution: On the Way to Control Over the Human Body
Grinin, L. E., Леонидович, Г. А., & Korotayev, A. (2024) · World-systems evolution and global futures · doi:10.1007/978-3-031-56764-3_8 · Cited by 3
AREG expression in cumulus cells as a prognostic marker of oocyte quality
Bashendjieva, E. O., Barashkova, E. A., Tatishcheva, J. A., Kalugina, A. S., & Enukashvily, N. I. (2024) · Translational Medicine · doi:10.18705/2311-4495-2024-11-5-407-418 · Cited by 3
Gaye, O., Ba, K., Diallo, M., Niasse, A., Counta, A. L., N’diaye, M. D., Gning, M., Gueye, A., & Fall, P. A. (2024) · Research and Reports in Urology · doi:10.2147/rru.s487854 · Cited by 5
Establishing oncofertility care in limited resource settings: a narrative review
Kimelman, D., & Ozimek, N. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03392-x · Cited by 3
Conceiving strife: Relational vulnerabilities in couples with male infertility in Pakistan
Amjad, U. (2025) · Journal of Critical Public Health · doi:10.55016/ojs/jcph.vi.79571 · Cited by 3
“These include relational vulnerabilities flowing from the financial strains of pursuing treatment (see Dupree 2018, Al-Kandari & Alenezi 2020, Njagi et al. 2023), Against this picture, on the other hand, Jamali Gandomani’s (2022) research on Iran suggested that not all couples succumbed to male…”
Chin, K. T.-C., Yiu, J. H. C., Cheung, K. W., Yuen, L. C., Wong, W. Y.-L., Cai, J., Cheung, S. W. M., Li, R., & Woo, C. W. (2025) · iScience · doi:10.1016/j.isci.2025.111933 · Cited by 2
Morin, F., Hughes, C. H. K., Roussel, V., Gevry, N., & Murphy, B. D. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf079 · Cited by 2
Hu, C., Zhai, L., & Wang, H. (2025) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.70103 · Cited by 2
“…of genetic causes of infertility, cultural differences, and the availability/accessibility of genetic testing in different parts of the world, constituting barriers to genetic testing (Ombelet 2011; Ethics Committee of the American Society for Reproductive Medicine 2021; Njagi et al. 2023).”
Tailoring clinical management after embryo transfer using β-hCG levels in resource-limited settings
Dhar, S., Adiga, P. K., Mundkur, A. S., Poojari, V. G., & Kumar, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-05851-y · Cited by 2
Pónusz-Kovács, D., Csákvári, T., Pónusz, R., Kovács, B., Kajos, L., Elmer, D., Bódis, J., Várnagy, Á., Vesztergom, D., & Boncz, I. (2025) · Orvosi Hetilap · doi:10.1556/650.2025.33330 · Cited by 3
Chiarot, A., Minhas, M., de Maat, N. M., Doan, J., Nilsson, M. I., Hettinga, B. P., Faghih, M., Neal, M. S., Nederveen, J. P., & Tarnopolsky, M. A. (2025) · Biomolecules · doi:10.3390/biom15091258 · Cited by 2
“Considering that the cost of assisted reproduction technologies (ARTs) may be pro-hibitive from a patient perspective [14–16], a more defined focus on low-cost preventive measures and adjunctive therapies may strengthen overall clinical practice and enhance the affordability of fertility treatments.”
After the Shock: Impact of Ectopic Pregnancy on Subsequent Fertility and Parenthood
Moustakli, E., Domali, E., Potiris, A., Gerede, A., Anagnostaki, I., Zikopoulos, A., Theofanakis, C., Kathopoulis, N., Louis, K., Drakakis, P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13092205 · Cited by 6
“ART is frequently inaccessible in LMICs, which exacerbates reproductive disparities [108].”
Metadata
- Authors
- Njagi, P., Groot, W., Arsenijevic, J., Dyer, S., Mburu, G., & Kiarie, J.
- Affiliations
- United Nations University – Maastricht Economic and Social Research Institute on Innovation and Technology (NL)
- Utrecht University (NL)
- University of Cape Town (ZA)
- World Health Organization (CH)
- Corresponding author
- Njagi, Purity
- Venue
- Human Reproduction Open
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-01-01
- Volume
- 2023
- Issue
- 2
- Pages
- hoad007-hoad007
- ISSN
- 2399-3529 (ISSN-L)
- PMC
- PMC10029849
- OpenAlex
- W4322730891
- Cited by
- 277
- References
- 65
- Citations by year
- 2026: 86 · 2025: 106 · 2024: 71 · 2023: 14
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Human Reproduction Open (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- Funders
- UNDP-UNFPA-UNICEF-WHO-World Bank
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- assisted reproduction, infertility treatment, direct medical costs, patient affordability, low- and middle-income countries, GDP per capita, ART regulation, access to fertility care, health policy implications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.